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Over the last few years several porcine epidemic diarrhoea (PED) out-
breaks have been discovered in Europe including the first PED case in Slovenia in 
January 2015. The aim of this study was to determine when PED virus (PEDV) 
infection started in Slovenia. Serum samples collected between 2012 and 2016 
were tested. Three hundred and seventy-five serum samples were collected from 
132 Slovenian small, one-site pig farms. Samples were tested for PEDV antibod-
ies utilising three different serological methods: commercially-available indirect 
ELISA, in-house blocking ELISA test and Immunoperoxidase Monolayer Assay 
(IPMA) test. One hundred and seventy (45.33%) tested samples were found posi-
tive by the commercially-available ELISA test kit, and 10 (5.68%) of these 170 
samples found positive were positive by the in-house blocking ELISA. Only these 
10 samples were collected from a farm where clinical signs of PED infection had 
been observed and PEDV was confirmed by RT-PCR methodology; the other 160 
samples were collected randomly. Thirty-two samples with the highest S/P value 
obtained with the commercial ELISA were all negative with IPMA. Reasons for 
the high variance in the results obtained remain unclear; more research is required 
to ensure higher sensitivity and specificity in terms of PEDV antibody tests and 
other PED diagnostic methods.  
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PEDV is a member of the Coronaviridae family. Based on genetic and an-
tigenic criteria, PEDV belongs to the Alphacoronavirus genus together with two 
other pig coronaviruses: transmissible gastroenteritis virus (TGEV) and porcine 
respiratory coronavirus (PRCV) (Jung and Saif, 2015). 
PED first appeared in the early 1970s in the United Kingdom (Wood, 
1977) and Belgium (Pensaert and de Bouck, 1978), and was first isolated in Bel-
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gium in 1977. Serological surveys in Europe during the 1980s and 1990s show a 
low to moderate prevalence of PEDV (Carvajal et al., 1995), with only sporadic 
outbreaks in The Netherlands (Pijpers et al., 1993), Hungary (Nagy et al., 1996) 
and England (Pritchard et al., 1999). The first laboratory-confirmed PED out-
break in Slovenia was diagnosed in January 2015 by means of the commercially-
available real-time reverse transcriptase polymerase chain reaction (RT-qPCR) 
on a fattening pig farm (Toplak et al., 2015). PED appears in epidemic and en-
demic forms, and is clinically dependent on the infecting PEDV strain. The clini-
cal signs for both PED forms are diarrhoea, vomiting, anorexia and appetite loss 
(Saif et al., 2012; Jung and Saif, 2015). In the case of epidemic PED, the severity 
of clinical signs and mortality appear to be inversely related to the pigs’ age 
(Jung and Saif, 2015), and the incubation period ranges from one to seven days 
(Stevenson et al., 2013). The clinical signs of endemic PED are mild and mostly 
limited to seronegative animals (Nagy et al., 1996; Jung and Saif, 2015). 
Few studies are available on anti-PEDV immune response and the im-
portance of serum antibody detection. The in-house, indirect, enzyme-linked 
immunosorbent assay (ELISA) is seen as a useful tool for detecting PEDV anti-
bodies in sera and colostrum (Gerber et al., 2014). 
The aim of this study was to determine when PEDV infection had started 
in Slovenia. For this purpose, serum samples collected between 2012 and 2016 
were tested utilising three different serological methods. 
Three hundred and seventy-five serum samples were collected from boars, 
breeding sows and older fattening pigs from 132 small, one-site pig farms be-
tween 2012 and 2016. Three hundred and sixty-five of the 375 samples were col-
lected at random from pig farms across Slovenia between 2012 and 2015, and 10 
samples were collected in April 2016 from a farm where clinical signs of PED 
had been observed. On this farm, PEDV was confirmed in the faeces with the 
commercially-available RT-PCR method (Virotype® PEDV/TGEV, Qiagen, Ger-
many). All animals were manipulated solely for diagnostic purposes. Serological 
testing was performed on all of the 375 collected samples using the commercial-
ly available ELISA Test Kit (Swinecheck® PED indirect ELISA Test Kit, Biovet, 
Canada). Testing was performed according to the producer’s manual (Biovet, 
2015). One hundred and seventy samples determined to be PEDV antibody posi-
tive using the commercially available ELISA test were further tested by means of 
the in-house blocking ELISA test (DTUVet, Denmark). The testing procedure 
was analogous to that used in a study published in 1997 (Sørensen et al., 1997). 
The 32 highest-ranking positive samples determined utilising the commercially 
available ELISA test kit were further tested by means of Immunoperoxidase 
Monolayer Assay (IPMA) (Bøtner et al., 1994). 
One hundred and seventy (45.33%) of the 375 samples tested were PEDV 
antibody positive with the commercially available ELISA test kit (Table 1), with 
the mean S/P value for the 170 positive samples being 1.076. None of the sam-
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ples tested by the in-house blocking ELISA test were determined positive. Ten 
positive samples collected from a PEDV-infected herd in 2016 were all found 
positive by means of the commercially available ELISA test kit and by in-house 
blocking ELISA testing. The 32 strongest positive samples obtained by means of 
the commercially available ELISA test kit, collected between 2012 and 2015 and 
with S/P ratios higher than 1.362, were all found negative by the in-house ELISA 
kit and IPMA. 
Table 1 
Number of tested samples and results for three tests used in this study 
PEDV antibody  
detection method 
Year (months) of  
sample collection 
Number of 
tested pigs 
Number of 
PEDV  
antibody 
positive pigs 
% of  
positive pigs 
Commercial ELISA test kit 2012 (Jan–Sep) 92 44 47.83 
 2013 (Feb–Oct) 91 51 56.04 
 2014 (Sep–Dec) 151 47 31.13 
 2015 (Jan–Jun) 31 18 58.06 
 2016 (Apr)* 10 10 100 
 Total 375 170 45.33 
In-house blocking ELISA 2012 (Jan–Sep) 44 0 0.00 
 2013 (Feb–Oct) 51 0 0.00 
 2014 (Sep–Dec) 47 0 0.00 
 2015 (Jan–Jun) 18 0 0.00 
 2016 (Apr)* 10 10 100.00 
 Total 375 170 45.33 
IPMA# 2012 (Jan–Sep) 10 0 0.00 
 2013 (Feb–Oct) 16 0 0.00 
 2014 (Sep–Dec) 6 0 0.00 
 2015 (Jan–Jun) 0 0 0.00 
 2016 (Apr)* NT NT NT 
 Total 32 0 0 
*Samples collected from PEDV-positive herd; #only those samples with S/P ratios higher than 
1.362 using the commercially available indirect ELISA test kit were tested using IPMA; NT – not 
tested 
 
Using the commercially available ELISA test kit, almost half of the tested 
sera samples (45.33%) collected before 2016 were interpreted as positive. At the 
time of testing, this was the only commercially available ELISA kit for the detec-
tion of PEDV antibodies on the market. As PED had never been suspected in 
Slovenia before 2015, this number seemed very high; we chose an in-house 
blocking ELISA test and IPMA for confirmatory testing based on the results of a 
ring trial from 2015 (Bøtner et al., 2015). All 160 samples previously found posi-
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tive with the commercially available ELISA test kit were negative by the in-
house ELISA testing. In addition, all 32 samples were also deemed negative pur-
suant to IPMA, suggesting that all results may be false positive when using the 
commercially available ELISA test kit. In April 2016, a clinical outbreak of 
PEDV infection occurred on a Slovenian pig fattening farm. All ten serum sam-
ples from this herd were found PEDV antibody positive by the commercially 
available ELISA test kit; these 10 samples were also sent to Denmark for retest-
ing by an in-house blocking ELISA test; this time, all 10 sera samples were 
found PEDV antibody positive. Samples for in-house blocking ELISA testing 
and IPMA were tested abroad and the high cost of these tests is the reason why 
only a limited number of primary samples were retested using both methods. As 
all of the 10 samples from the farm with PEDV clinical signs were found posi-
tive by the commercially available and the in-house ELISA tests, respectively, 
IPMA testing was not chosen for further confirmation. 
The reasons for the discrepancy in the obtained results are difficult to de-
termine. One reason may be that the vast majority of samples in our study (365 
out of 375; 97.33%) were randomly collected from the field between 2012 and 
2015 for the purpose of monitoring Aujeszky’s disease and classical swine fever 
(CSF). These animals were mainly breeding sows and boars, and a few older fat-
teners. As the producer of the commercially available ELISA test kit states (Bio-
vet, 2015), this commercially available test successfully detects PEDV antibod-
ies up to 42 days post infection; after that, testing is not clear. As PED mostly af-
fects suckling piglets, weaners and young fatteners (Shibata et al., 2000; Pura-
naveja et al., 2009; Saif et al., 2012), these 365 pigs, even if affected when young 
and had recovered from PEDV, were past this 42-day limit, so we believe that it 
is possible that non-specific reactions may be evidenced when using this com-
mercially available kit on sera from these animals, and that results could be false 
positive. When the commercially available kit was used on younger fatteners 
with distinct clinical PED signs in 2016, the results seemed to be accurate and in 
accordance with those of the in-house ELISA testing. Therefore, we believe that 
the commercially available kit is, in fact, useful for the detection of antibodies at 
certain stages, such as after infection, vaccination or natural exposure. In our 
case, where we wanted to determine seroprevalence in Slovenia, the usefulness 
of this commercially available ELISA test kit was questionable. A more exact 
evaluation of result dissimilarity in relation to the three different methods utilised 
and the implementation of gold standard tests would be of great value. More 
complete studies on antibody response to PED are needed to enhance the per-
formance of new PEDV antibody detection methods with higher specificity. 
Since the beginning of this study, new commercial ELISA kits have become 
available for the detection of PEDV antibodies and their specificities and sensi-
tivities have been compared (Leidenberger et al., 2017). Although the results of 
this study also showed some variability, more commercial diagnostic tools for 
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the detection of PEDV antibodies are becoming available, meaning that in the 
case of uncertainty, there are some commercial tools available for comparison. If 
positive results are obtained from pigs, especially older pigs with no clinical 
signs of PED, we would recommend that samples are re-tested with one of the 
serological methods from the OIE PED technical factsheet [ELISA, either com-
mercial or in-house, immunofluorescence test, immunohistochemistry test or se-
rum neutralisation test (OIE, 2014)]. 
The detection of PEDV in Slovenia and other confirmed PED cases in Eu-
rope in 2015 represent a potential threat to the swine industry. The reason for the 
high variance in results obtained by the different methods used in this study is 
unclear. Commercially available methods for detecting PEDV antibodies effi-
ciently for at least one year after exposure would be greatly appreciated in cases 
of PED emergency in Europe and for the purpose of PED prevalence monitoring. 
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